ASPIRA PATHLAB & DIAGNOSTICS | KMC SPECIALITY HOSPITALS | ASPIRA PATHLAB & DIAGNOSTICS / KMC SPECIALITY HOSPITALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.4 | 48.5 | - | View Chart |
P/BV | x | 2.6 | 13.1 | 19.5% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
ASPIRA PATHLAB & DIAGNOSTICS KMC SPECIALITY HOSPITALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
KMC SPECIALITY HOSPITALS Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / KMC SPECIALITY HOSPITALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 73 | 102.7% | |
Low | Rs | 26 | 50 | 51.3% | |
Sales per share (Unadj.) | Rs | 14.0 | 9.6 | 147.1% | |
Earnings per share (Unadj.) | Rs | -0.1 | 1.6 | -5.3% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 2.1 | 69.1% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 12.4 | 7.0 | 178.0% | |
Shares outstanding (eoy) | m | 10.29 | 163.09 | 6.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 6.4 | 55.6% | |
Avg P/E ratio | x | -583.7 | 37.6 | -1,553.1% | |
P/CF ratio (eoy) | x | 34.6 | 29.2 | 118.4% | |
Price / Book Value ratio | x | 4.1 | 8.8 | 46.0% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 518 | 10,030 | 5.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 312 | 17.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 1,558 | 9.3% | |
Other income | Rs m | 3 | 35 | 9.2% | |
Total revenues | Rs m | 148 | 1,592 | 9.3% | |
Gross profit | Rs m | 16 | 413 | 3.9% | |
Depreciation | Rs m | 16 | 76 | 20.8% | |
Interest | Rs m | 4 | 11 | 37.0% | |
Profit before tax | Rs m | -1 | 360 | -0.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 93 | 0.0% | |
Profit after tax | Rs m | -1 | 267 | -0.3% | |
Gross profit margin | % | 11.0 | 26.5 | 41.6% | |
Effective tax rate | % | 0 | 25.8 | -0.0% | |
Net profit margin | % | -0.6 | 17.1 | -3.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 519 | 11.3% | |
Current liabilities | Rs m | 16 | 225 | 7.0% | |
Net working cap to sales | % | 29.5 | 18.8 | 157.0% | |
Current ratio | x | 3.7 | 2.3 | 160.6% | |
Inventory Days | Days | 88 | 103 | 85.4% | |
Debtors Days | Days | 590 | 102 | 576.0% | |
Net fixed assets | Rs m | 115 | 1,621 | 7.1% | |
Share capital | Rs m | 103 | 163 | 63.1% | |
"Free" reserves | Rs m | 25 | 972 | 2.5% | |
Net worth | Rs m | 128 | 1,135 | 11.2% | |
Long term debt | Rs m | 10 | 399 | 2.4% | |
Total assets | Rs m | 173 | 2,140 | 8.1% | |
Interest coverage | x | 0.8 | 32.9 | 2.4% | |
Debt to equity ratio | x | 0.1 | 0.4 | 21.5% | |
Sales to assets ratio | x | 0.8 | 0.7 | 114.5% | |
Return on assets | % | 1.9 | 13.0 | 14.6% | |
Return on equity | % | -0.7 | 23.5 | -3.0% | |
Return on capital | % | 2.4 | 24.2 | 9.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 1 | 0.0% | |
Net fx | Rs m | 0 | -1 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 323 | -0.0% | |
From Investments | Rs m | 2 | -480 | -0.3% | |
From Financial Activity | Rs m | -9 | 158 | -5.9% | |
Net Cashflow | Rs m | -8 | 2 | -463.5% |
Indian Promoters | % | 18.7 | 75.0 | 25.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 25.0 | 325.1% | |
Shareholders | 1,512 | 86,328 | 1.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE NARAYANA HRUDAYALAYA KIMS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | KMC SPECIALITY HOSPITALS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.14% | -0.14% | -0.44% |
1-Month | -8.93% | 6.79% | -0.53% |
1-Year | -3.33% | 51.19% | 53.10% |
3-Year CAGR | 1.86% | 39.45% | 14.74% |
5-Year CAGR | -1.91% | 46.75% | 19.69% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the KMC SPECIALITY HOSPITALS share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of KMC SPECIALITY HOSPITALS the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of KMC SPECIALITY HOSPITALS.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
KMC SPECIALITY HOSPITALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of KMC SPECIALITY HOSPITALS.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.